VeriMom¿Es salicyloyl phytosphingosine seguro durante el embarazo?
No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
Pregnancy-safe products containing salicyloyl phytosphingosine
Related ingredients
Frequently asked questions
- ¿Es salicyloyl phytosphingosine seguro durante el embarazo?
- No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- ¿Es salicyloyl phytosphingosine seguro durante la lactancia?
- No data on transfer into breast milk or breastfeeding-associated studies were found; with no reproductive or developmental toxicity signals and low expected systemic absorption from topical cosmetics, hazard is not indicated. Exposure is considered low but measurable as for pregnancy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- ¿Es salicyloyl phytosphingosine seguro para la piel del bebé?
- No infant‑specific toxicity data were identified. Following the user's scoring rules, because the ingredient has measurable (though low) dermal exposure in adults (see above) baby exposure is increased by +1 due to immature barrier and higher surface‑area‑to‑weight; there are still no data suggesting developmental/dermal hazard for infants. The literature describes topical skin benefits (barrier repair, anti‑inflammatory) rather than harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- ¿Cómo puntúa VeriMom a salicyloyl phytosphingosine?
- VeriMom puntúa salicyloyl phytosphingosine en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a salicyloyl phytosphingosine en el embarazo?
- Consulta nuestra lista de alternativas seguras a salicyloyl phytosphingosine según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.